Drug Profile
Islet cell transplant therapy - Ixion
Alternative Names: IxSC-1Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ixion Biotechnology
- Class
- Mechanism of Action Pancreatic beta cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in USA
- 02 Jul 2004 Preclinical trials in Diabetes mellitus in USA (unspecified route)